Single Agent Alimta in Poor Performance Status in Patients With Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Mar 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2016, according to ClinicalTrials.gov record.
- 12 Mar 2015 Status changed from completed to active, no longer recruiting, according to ClinicalTrials.gov record.